Teknova announces closing of $22.9 million concurrent registered direct offering and private placement and amends credit facility

Hollister, calif., sept. 19, 2023 (globe newswire) -- alpha teknova, inc. (“teknova”) (nasdaq: tkno), a leading producer of critical reagents for the research, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced the closing of its previously announced registered direct offering for the issuance and sale of an aggregate of 1,086,485 of its shares of common stock at a purchase price of $1.85 per share and concurrent private placement of an aggregate of 11,299,993 of its shares of common stock, at the same purchase price of $1.85 per share. the registered direct offering and the private placement were priced based on the consolidated closing bid price under nasdaq rules.
TKNO Ratings Summary
TKNO Quant Ranking